Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 69826-69827 [2016-24365]
Download as PDF
<![CDATA[
69826
Federal Register / Vol. 81, No. 195 / Friday, October 7, 2016 / Notices
results returned to DHANES/NCHS, the
test results will be made available to the
public and the investigator can submit
an NCHS RDC proposal to request
linkage to NCHS restricted data, NCHS
public use data, or Non-NCHS data to
conduct their analysis.
After the comprehensive quality
assessment process has been completed
by the investigator, a list of variants
generated from NHANES specimen
testing will be made available to the
public for potential solicitation via
NCHS RDC proposals. The list of
variants will be available in the
NHANES Genetic Variant Search
(https://www.nhgeneticvariant.com/). In
addition, DHANES/NCHS quality
control assessment procedures will be
posted on the NHANES Genetic
Repository Web site and/or available via
email.
Progress Reports
A progress report will be submitted in
the annual CDC/NCHS/ERB
continuation report. An ERB
continuation form will be sent to the
investigator each year for project
update. If an approved proposal is
unable to obtain funding the proposal
will be closed.
Termination of ERB Protocol
At the end of laboratory testing the
ERB Protocol will be closed.
Disposition of Results and Samples
The provided DNA samples cannot be
used for any purpose other than the
specifically requested purpose outlined
in the proposal and approved through
the Scientific and Institutional Review.
No DNA samples can be shared with
others, including other investigators,
unless specified in the proposal and so
approved. Samples must be returned
upon completion of the approved
project or destroyed only with the
written approval of the NHANES
Genetic Project Officer. Test results from
all studies using NHANES DNA
specimens will be made available to the
public for secondary data analyses.
After the DHANES/NCHS quality
control assessment is completed,
investigators will be given up to six
months to conduct a more
comprehensive quality assurance
review. The final quality assurance
review timeframe will be negotiated
between the researcher and the
NHANES Genetic Project Officer and
characteristics of the tests submitted.
Proposals for secondary data analyses
will be reviewed by the NCHS RDC on
a rolling basis; see: https://www.cdc.gov/
rdc for proposal guidelines. All data
analyses will be conducted via access
modes available at NCHS RDC.
Dated: October 4, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
TABLE 1—COST SCHEDULE FOR NHANES DNA SPECIMENS
1999–2002,
2007–08,
2009–10
Complete set
Total costs
Materials and Equipment—contractor: Plates, reagents, assays, aliquoting and packaging
samples; use of equipment ......................................................................................................
Labor—contractor: Processing, handling, and shipping; NCHS: Data quality control ................
Proposal review and Administrative expenses—contractor: Inventory management and reporting; NCHS: Management of proposal process non-NCHS: Technical panel fees ............
Space—contractor: Freezer use and maintenance .....................................................................
Cost per sample ..........................................................................................................................
Cost per new proposal:
1999–2002 ............................................................................................................................
2007–2008 ............................................................................................................................
2009–2010 ............................................................................................................................
III ...........................................................................................................................................
Cost per additional proposal: *
1999–2002 ............................................................................................................................
2007–2008 ............................................................................................................................
2009–2010 ............................................................................................................................
III ...........................................................................................................................................
1999–2002,
2007–08,
2009–10
Partial set
NHANES III
complete set
$1.51
4.98
$4.53
24.90
$0.75
2.49
3.02
5.59
15.10
6.04
5.59
41.06
1.51
2.79
7.55
119,260
72,661
73,884
........................
NA
5,963
3,633
3,694
........................
........................
54,050
**
........................
2,702
* Additional research using DNA specimens already obtained from previous solicitations.
** This charge will be 5 percent of the original cost.
Note: Applicable CDC overhead and NCHS management and oversight charges will be added to these rates for proposals coming from Federal agencies.
[FR Doc. 2016–24349 Filed 10–6–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK3G9T082PROD with NOTICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
Amendment: A notice of this meeting
was published in the Federal Register
on August 30, 2016, Volume 81,
Number 168, Page 59626. The original
notice is amended to include the
VerDate Sep<11>2014
17:36 Oct 06, 2016
Jkt 241001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS) Meeting on
October 19, 2016 as follows:
Time and Date: 8:00 a.m.–4:00 p.m.,
EDT, October 19, 2016.
Place: CDC, Building 19, Room 151,
1600 Clifton Road NE., Atlanta, Georgia
30329.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 50
people. The public is welcome to
participate during the public comment
E:\FR\FM\07OCN1.SGM
07OCN1
Federal Register / Vol. 81, No. 195 / Friday, October 7, 2016 / Notices
period, which is tentatively scheduled
from 3:45 p.m. to 3:55 p.m. This
meeting is also available by
teleconference. Please dial (888) 324–
9970 and enter code 32077657.
Purpose: The Subcommittee will
contribute to the ACD’s advice to the
CDC Director on strategic and other
health disparities and health equity
issues and provide guidance on
opportunities for CDC.
Matters for Discussion: The Health
Disparities Subcommittee will receive
update from STLT Social Determinants
of Health (SDOH) Think Tank
Collaboration, Funding Opportunity
Announcement (FOA) Health Equity
Guidance Update and Discussion, HDS
priorities, Internal Nomination Process
and Update, Health Equity Indicators as
well as an update from CDC’s Principal
Deputy Director.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta,
Georgia 30329 Telephone (770) 488–
8343, Email: xdy8@cdc.gov. The
Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–24365 Filed 10–6–16; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2016–0092]
2018 National Health Interview Survey
Questionnaire Redesign
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
mstockstill on DSK3G9T082PROD with NOTICES
AGENCY:
The National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC),
in the Department of Health and Human
Services (HHS) announces the opening
SUMMARY:
VerDate Sep<11>2014
17:36 Oct 06, 2016
Jkt 241001
of a docket to obtain public comment on
the redesign of the National Health
Interview Survey (NHIS) questionnaire
(OMB Control No. 0920–0214, expires
01/31/2019) Any proposed changes will
be submitted in future notices in
compliance with the Paperwork
Reduction Act (PRA). The content and
structure of the NHIS will be updated in
2018 to improve the measurement of
covered health topics, reduce
respondent burden by shortening the
length of the questionnaire, harmonize
overlapping content with other federal
health surveys, establish a long-term
structure of ongoing and periodic topics,
and incorporate advances in survey
methodology and measurement.
DATES: Written comments must be
received on or before November 7, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0092 by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Verita C. Buie, Office of
Planning, Budget, and Legislation,
National Center for Health Statistics,
Centers for Disease Control and
Prevention, 3311 Toledo Road, MS–08,
Hyattsville, MD 20782.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Marcie Cynamon, Director, of the
Division of Health Interview Statistics,
National Center for Health Statistics,
3311 Toledo Road, MS–P08, Hyattsville,
MD 20782–2064, phone: (301) 458–
4174.
SUPPLEMENTARY INFORMATION: The
National Center for Health Statistics
(NCHS) is redesigning the National
Health Interview Survey (NHIS) to be
fielded in 2018. The NHIS is the
principal source of information on the
health of the civilian
noninstitutionalized population of the
United States. Established by the
National Health Survey Act of 1956, the
survey has been in the field
continuously since July 1957. NHIS data
are used widely throughout the
Department of Health and Human
Services (HHS) to monitor trends in
illness and disability and to track
progress toward achieving national
health objectives. The data are used by
HHS and the public health research
community in determining barriers to
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
69827
accessing and using health care services,
and in tracking those health conditions
and behaviors related to the leading
causes of morbidity and mortality.
The redesigned NHIS questionnaire
and survey structure will be introduced
in January 2018. The redesign process
presents an opportunity to (1) ensure
the survey is capturing the current
health and health care needs of
individuals in the United States and
producing data of the highest-possible
quality; and (2) reduce respondent
burden by shortening the overall
questionnaire length and harmonizing
its content with other federal health
surveys. The redesign is strategically
timed to coordinate with the data cycle
used to monitor Healthy People 2020
objectives, providing a clean transition
into the next decade of monitoring the
nation’s critical public health
indicators. The redesigned
questionnaire reflects advances in
survey methodology and measurement
since the last NHIS redesign in 1997.
This proposal incorporates a long-term
structure for the content of the survey.
There will be content that remains on
the survey each year and content that
will be collected on a rotating basis
(collected for one or two years, off for
one year). The periodicity of rotating
content will be established several years
in advance. Approximately 15 to 20
minutes of interview time each year will
be reserved for sponsored content that
addresses the data needs of other federal
agencies and partners.
The proposed structure of the
redesigned NHIS will differ from the
current structure. Since 1997, the NHIS
has consisted of a family questionnaire,
a sample adult questionnaire, and a
sample child questionnaire. The new
structure will include a sample adult
questionnaire and a sample child
questionnaire only; however, in the
redesigned NHIS, much of the content
from the family section will be collected
within the sample adult and sample
child interviews. To complete these
questionnaires, one adult aged 18 years
and over and one child aged 17 years
and under (if applicable) will be
randomly selected from each sampled
household. Information about the
sample adult will be collected from the
sample adult himself/herself unless s/he
is physically or mentally unable to do
so, in which case a knowledgeable
proxy will be allowed to answer for the
sample adult. Information about the
sample child will be collected from a
knowledgeable adult who may or may
not also be the sample adult.
Content from the family questionnaire
that will still be obtained from
respondents in the redesigned NHIS
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 81, Number 195 (Friday, October 7, 2016)]
[Notices]
[Pages 69826-69827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24365]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
Amendment: A notice of this meeting was published in the Federal
Register on August 30, 2016, Volume 81, Number 168, Page 59626. The
original notice is amended to include the Advisory Committee to the
Director (ACD), Centers for Disease Control and Prevention--Health
Disparities Subcommittee (HDS) Meeting on October 19, 2016 as follows:
Time and Date: 8:00 a.m.-4:00 p.m., EDT, October 19, 2016.
Place: CDC, Building 19, Room 151, 1600 Clifton Road NE., Atlanta,
Georgia 30329.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people. The public is
welcome to participate during the public comment
[[Page 69827]]
period, which is tentatively scheduled from 3:45 p.m. to 3:55 p.m. This
meeting is also available by teleconference. Please dial (888) 324-9970
and enter code 32077657.
Purpose: The Subcommittee will contribute to the ACD's advice to
the CDC Director on strategic and other health disparities and health
equity issues and provide guidance on opportunities for CDC.
Matters for Discussion: The Health Disparities Subcommittee will
receive update from STLT Social Determinants of Health (SDOH) Think
Tank Collaboration, Funding Opportunity Announcement (FOA) Health
Equity Guidance Update and Discussion, HDS priorities, Internal
Nomination Process and Update, Health Equity Indicators as well as an
update from CDC's Principal Deputy Director.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, Health Disparities
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton
Road NE., M/S K-77, Atlanta, Georgia 30329 Telephone (770) 488-8343,
Email: xdy8@cdc.gov. The Director, Management Analysis and Services
Office, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-24365 Filed 10-6-16; 8:45 am]
BILLING CODE 4160-18-P
